Jafar Al-Mondhiry, MD, MA (@mondhiry) 's Twitter Profile
Jafar Al-Mondhiry, MD, MA

@mondhiry

Medical oncologist focused on #melanoma @InovaSchar | #PalliativeCare Advocate | #MedEd Goals | @COREIMPodcast Producer/Host | #GirlDad x3 | Tweets = my own

ID: 1141626843235094529

calendar_today20-06-2019 08:40:24

858 Tweet

379 Followers

234 Following

Hank Green (@hankgreen) 's Twitter Profile Photo

As part of the research for my (someday upcoming) cancer book, I went to some “functional medicine” appointments to see what the appeal was and I am very glad I did it. Here are two parts of it that I think lead people to engage with non-evidence based healthcare. The first is

CORE IM (@coreimpodcast) 's Twitter Profile Photo

1/ 🚨 NEW #AtTheBedside: Moral Distress Part 1: Definitions, Causes & Consequences Time to really name, talk about, and hopefully unpack some of the hidden weight we carry in the practice of medicine ⤵️ 🖥️: coreimpodcast.com/2024/09/11/mor… Sponsor: Panacea Financial

1/ 🚨 NEW #AtTheBedside: Moral Distress Part 1: Definitions, Causes & Consequences

Time to really name, talk about, and hopefully unpack some of the hidden weight we carry in the practice of medicine ⤵️ 

🖥️: coreimpodcast.com/2024/09/11/mor… 
Sponsor: <a href="/Pan_Financial/">Panacea Financial</a>
CORE IM (@coreimpodcast) 's Twitter Profile Photo

1/ 🚨 NEW #AtTheBedside: Moral Distress Part 2: Strategies & Solutions The FIRST and most important step in addressing moral distress:  ❤️‍🩹Naming it We must identify what we’re actually feeling 🖥️: coreimpodcast.com/2024/09/18/mor…

1/ 🚨 NEW #AtTheBedside: Moral Distress Part 2: Strategies &amp; Solutions

The FIRST and most important step in addressing moral distress:  

❤️‍🩹Naming it

We must identify what we’re actually feeling 

🖥️: coreimpodcast.com/2024/09/18/mor…
Jafar Al-Mondhiry, MD, MA (@mondhiry) 's Twitter Profile Photo

So excited to take part in Dr. Nagla Abdel Karim’s excellent oncology symposium on early drug development — we live in a dizzying world of #oncology drug advances, with more happening daily than ever before! Looking forward to bringing #TIL therapy for pts w/ melanoma Inova Schar Cancer Institute soon!

Jafar Al-Mondhiry, MD, MA (@mondhiry) 's Twitter Profile Photo

I am continually impressed with the level of hem/onc applicants Inova Schar Cancer Institute — sometimes it feels like an impossible academic arms race to see how many publications each candidate can get! On a less cynical note, I’d like to think that our specialty’s future looks bright 🌟🤩☀️

Dr Joseph McCollom DO (@realbowtiedoc) 's Twitter Profile Photo

Charles von Gunten is a true #pallonc legend and foundational for #hpm #hapc training. Grateful to have caught him at #hapc23 Join our ASCO PallOnc Community of Practice crew on Oct 24th 4p EST for a fireside chat with many of program directors of these innovative #supponc fellowships too!

<a href="/CvonGunten/">Charles von Gunten</a> is a true #pallonc legend and foundational for #hpm #hapc training. Grateful to have caught him at #hapc23 

Join our <a href="/PallOncCoP/">ASCO PallOnc Community of Practice</a> crew on Oct 24th 4p EST for a fireside chat with many of program directors of these innovative #supponc fellowships too!
Ramy Sedhom, MD, FASCO (@ramsedhom) 's Twitter Profile Photo

🍇 Thrilled to share our latest article in Journal of Geriatric Oncology "Three lessons from 'The Fox and the Grapes' to inform precision oncology in older adults" Led by 🌟fellow Gabriel Aleixo sciencedirect.com/science/articl… This timeless fable offers a lens to improve geriatric oncology care 🧵👇

Jafar Al-Mondhiry, MD, MA (@mondhiry) 's Twitter Profile Photo

Older adults feel these challenges most acutely & urgently, but the gap between clinical trial outcomes designed by industry & academia vs those that matter to patients is a problem for our entire field to confront. We can find new, meaningful grapes for patients beyond PFS/OS.